Related references
Note: Only part of the references are listed.Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better
Ming Zheng
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol
Linea Natalie Toksvang et al.
BMC CANCER (2022)
DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia
Linea Natalie Toksvang et al.
LEUKEMIA (2022)
DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysis
Linea N. Toksvang et al.
LEUKEMIA (2022)
Revisiting the role of CD4+T cells in cancer immunotherapy-new insights into old paradigms
Rong En Tay et al.
CANCER GENE THERAPY (2021)
The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
Denis L. Jardim et al.
CANCER CELL (2021)
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Kevin Litchfield et al.
CELL (2021)
Paradigms on Immunotherapy Combinations with Chemotherapy
Diego Salas-Benito et al.
CANCER DISCOVERY (2021)
Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer
Xue-lin Zou et al.
FRONTIERS IN IMMUNOLOGY (2021)
Loss of Ambra1 promotes melanoma growth and invasion
Luca Di Leo et al.
NATURE COMMUNICATIONS (2021)
Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy
Peipei Wang et al.
FRONTIERS IN ONCOLOGY (2021)
Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia
Rikke Hebo Larsen et al.
HAEMATOLOGICA (2021)
Enhanced Antitumor Response to Immune Checkpoint Blockade Exerted by Cisplatin-Induced Mutagenesis in a Murine Melanoma Model
Falih M. Gorgun et al.
FRONTIERS IN ONCOLOGY (2021)
Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy
Mark Lee et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Current issues and perspectives in PD-1 blockade cancer immunotherapy
Kenji Chamoto et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Qingyang Lei et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
The Roles of CD8(+) T Cell Subsets in Antitumor Immunity
Michael St Paul et al.
TRENDS IN CELL BIOLOGY (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
The association between monocytic myeloid-derived suppressor cells levels and the anti-tumor efficacy of anti-PD-1 therapy in NSCLC patients
Jiuxing Feng et al.
TRANSLATIONAL ONCOLOGY (2020)
Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma
Valsamo Anagnostou et al.
CELL REPORTS MEDICINE (2020)
Using flow cytometry for mitochondrial assays
Lauar de Brito Monteiro et al.
METHODSX (2020)
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fucikova et al.
CELL DEATH & DISEASE (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy
Emily J. Lelliott et al.
SCIENTIFIC REPORTS (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
Saman Maleki Vareki
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial
Stine Nygaard Nielsen et al.
LANCET ONCOLOGY (2017)
UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model
Jake Wang et al.
PIGMENT CELL & MELANOMA RESEARCH (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations
Katrina Meeth et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells
Blanca Homet Moreno et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Exit Strategies: S1P Signaling and T Cell Migration
Audrey Baeyens et al.
TRENDS IN IMMUNOLOGY (2015)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
The Availability of a Functional Tumor Targeting T-Cell Repertoire Determines the Anti-Tumor Efficiency of Combination Therapy with Anti-CTLA-4 and Anti-4-1BB Antibodies
Benjamin A. H. Jensen et al.
PLOS ONE (2013)
Liquid chromatography-tandem mass spectrometry quantification of 6-thioguanine in DNA using endogenous guanine as internal standard
Jack H. Jacobsen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth
Taku Fujimura et al.
ONCOIMMUNOLOGY (2012)
Fast and accurate long-read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2010)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer
Peter Karran et al.
NATURE REVIEWS CANCER (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods
M Shipkova et al.
CLINICAL CHEMISTRY (2003)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
V Brinkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
